ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global New Chemical Entities (NCE) Market Research Report 2026
Published Date: 2026-01-22
|
Report Code: QYRE-Auto-24J18569
Home | Market Reports
Global New Chemical Entities NCE Market Research Report 2025
BUY CHAPTERS

Global New Chemical Entities (NCE) Market Research Report 2026

Code: QYRE-Auto-24J18569
Report
2026-01-22
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
KATSURA CHEMICAL CO., LTD
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm Ltd.
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences (Nanjing), Inc.
NMS Group (Accelera Srl)

New Chemical Entities (NCE) Market Size

The global New Chemical Entities (NCE) market was valued at US$ 4992 million in 2025 and is anticipated to reach US$ 10420 million by 2032, at a CAGR of 11.2% from 2026 to 2032.

New Chemical Entities (NCE) Market

New Chemical Entities (NCE) Market

During the drug discovery process, new compounds or active moieties (molecules or ions responsible for physiological or pharmacological action) can arise that have not previously been FDA-approved. These compounds are called New Chemical Entities (NCE) as they have not previously been used, and they can help bring about cures and therapies for incurable diseases such as cancer due to the novelty of the drug and or compound.In the existing market, there are already companies providing CDMO services for new chemical entities, and there are also companies providing new chemical entity discovery services, which can then be handed over to other companies for drug development.
The North American market for New Chemical Entities (NCE) is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for New Chemical Entities (NCE) is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for New Chemical Entities (NCE) in Tumors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of New Chemical Entities (NCE) include KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global New Chemical Entities (NCE) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding New Chemical Entities (NCE). The New Chemical Entities (NCE) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global New Chemical Entities (NCE) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist New Chemical Entities (NCE) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of New Chemical Entities (NCE) Market Report

Report Metric Details
Report Name New Chemical Entities (NCE) Market
Accounted market size in 2025 US$ 4992 in million
Forecasted market size in 2032 US$ 10420 million
CAGR 11.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • NCE Discovery
  • Drug Formulation Development
  • Large-scale Manufacturing
Segment by Application
  • Tumors
  • Cardiovascular Diseases
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, Neuland Laboratories, Piramal Pharma Solutions, Sai Life Sciences, Chempro Pharma, LG Chem, Sofpromed, Aurigene Pharmaceutical Services Ltd., Aragen Life Sciences Ltd, WuXi AppTec, PharmaBlock Sciences Nanjing Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for New Chemical Entities (NCE) companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is New Chemical Entities (NCE) Market growing?

Ans: The New Chemical Entities (NCE) Market witnessing a CAGR of 11.2% during the forecast period 2026-2032.

What is the New Chemical Entities (NCE) Market size in 2032?

Ans: The New Chemical Entities (NCE) Market size in 2032 will be US$ 10420 million.

Who are the main players in the New Chemical Entities (NCE) Market report?

Ans: The main players in the New Chemical Entities (NCE) Market are KATSURA CHEMICAL CO., LTD, NMS Group (Accelera Srl), Adragos Pharma, Syngene, Regis Custom API, Bachem, Suven Pharma, Aspen API, MedPharm, Intertek, Neuland Laboratories, Piramal Pharma Solutions, Sai Life Sciences, Chempro Pharma, LG Chem, Sofpromed, Aurigene Pharmaceutical Services Ltd., Aragen Life Sciences Ltd, WuXi AppTec, PharmaBlock Sciences Nanjing Inc

What are the Application segmentation covered in the New Chemical Entities (NCE) Market report?

Ans: The Applications covered in the New Chemical Entities (NCE) Market report are Tumors, Cardiovascular Diseases, Other

What are the Type segmentation covered in the New Chemical Entities (NCE) Market report?

Ans: The Types covered in the New Chemical Entities (NCE) Market report are NCE Discovery, Drug Formulation Development, Large-scale Manufacturing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global New Chemical Entities (NCE) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 NCE Discovery
1.2.3 Drug Formulation Development
1.2.4 Large-scale Manufacturing
1.3 Market by Application
1.3.1 Global New Chemical Entities (NCE) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Tumors
1.3.3 Cardiovascular Diseases
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global New Chemical Entities (NCE) Market Perspective (2021–2032)
2.2 Global New Chemical Entities (NCE) Growth Trends by Region
2.2.1 Global New Chemical Entities (NCE) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 New Chemical Entities (NCE) Historic Market Size by Region (2021–2026)
2.2.3 New Chemical Entities (NCE) Forecasted Market Size by Region (2027–2032)
2.3 New Chemical Entities (NCE) Market Dynamics
2.3.1 New Chemical Entities (NCE) Industry Trends
2.3.2 New Chemical Entities (NCE) Market Drivers
2.3.3 New Chemical Entities (NCE) Market Challenges
2.3.4 New Chemical Entities (NCE) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top New Chemical Entities (NCE) Players by Revenue
3.1.1 Global Top New Chemical Entities (NCE) Players by Revenue (2021–2026)
3.1.2 Global New Chemical Entities (NCE) Revenue Market Share by Players (2021–2026)
3.2 Global Top New Chemical Entities (NCE) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by New Chemical Entities (NCE) Revenue
3.4 Global New Chemical Entities (NCE) Market Concentration Ratio
3.4.1 Global New Chemical Entities (NCE) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by New Chemical Entities (NCE) Revenue in 2025
3.5 Global Key Players of New Chemical Entities (NCE) Head Offices and Areas Served
3.6 Global Key Players of New Chemical Entities (NCE), Products and Applications
3.7 Global Key Players of New Chemical Entities (NCE), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 New Chemical Entities (NCE) Breakdown Data by Type
4.1 Global New Chemical Entities (NCE) Historic Market Size by Type (2021–2026)
4.2 Global New Chemical Entities (NCE) Forecasted Market Size by Type (2027–2032)
5 New Chemical Entities (NCE) Breakdown Data by Application
5.1 Global New Chemical Entities (NCE) Historic Market Size by Application (2021–2026)
5.2 Global New Chemical Entities (NCE) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America New Chemical Entities (NCE) Market Size (2021–2032)
6.2 North America New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America New Chemical Entities (NCE) Market Size by Country (2021–2026)
6.4 North America New Chemical Entities (NCE) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe New Chemical Entities (NCE) Market Size (2021–2032)
7.2 Europe New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe New Chemical Entities (NCE) Market Size by Country (2021–2026)
7.4 Europe New Chemical Entities (NCE) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific New Chemical Entities (NCE) Market Size (2021–2032)
8.2 Asia-Pacific New Chemical Entities (NCE) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2021–2026)
8.4 Asia-Pacific New Chemical Entities (NCE) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America New Chemical Entities (NCE) Market Size (2021–2032)
9.2 Latin America New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America New Chemical Entities (NCE) Market Size by Country (2021–2026)
9.4 Latin America New Chemical Entities (NCE) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa New Chemical Entities (NCE) Market Size (2021–2032)
10.2 Middle East & Africa New Chemical Entities (NCE) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2021–2026)
10.4 Middle East & Africa New Chemical Entities (NCE) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Details
11.1.2 KATSURA CHEMICAL CO., LTD Business Overview
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Introduction
11.1.4 KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.1.5 KATSURA CHEMICAL CO., LTD Recent Development
11.2 NMS Group (Accelera Srl)
11.2.1 NMS Group (Accelera Srl) Company Details
11.2.2 NMS Group (Accelera Srl) Business Overview
11.2.3 NMS Group (Accelera Srl) New Chemical Entities (NCE) Introduction
11.2.4 NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.2.5 NMS Group (Accelera Srl) Recent Development
11.3 Adragos Pharma
11.3.1 Adragos Pharma Company Details
11.3.2 Adragos Pharma Business Overview
11.3.3 Adragos Pharma New Chemical Entities (NCE) Introduction
11.3.4 Adragos Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.3.5 Adragos Pharma Recent Development
11.4 Syngene
11.4.1 Syngene Company Details
11.4.2 Syngene Business Overview
11.4.3 Syngene New Chemical Entities (NCE) Introduction
11.4.4 Syngene Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.4.5 Syngene Recent Development
11.5 Regis Custom API
11.5.1 Regis Custom API Company Details
11.5.2 Regis Custom API Business Overview
11.5.3 Regis Custom API New Chemical Entities (NCE) Introduction
11.5.4 Regis Custom API Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.5.5 Regis Custom API Recent Development
11.6 Bachem
11.6.1 Bachem Company Details
11.6.2 Bachem Business Overview
11.6.3 Bachem New Chemical Entities (NCE) Introduction
11.6.4 Bachem Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.6.5 Bachem Recent Development
11.7 Suven Pharma
11.7.1 Suven Pharma Company Details
11.7.2 Suven Pharma Business Overview
11.7.3 Suven Pharma New Chemical Entities (NCE) Introduction
11.7.4 Suven Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.7.5 Suven Pharma Recent Development
11.8 Aspen API
11.8.1 Aspen API Company Details
11.8.2 Aspen API Business Overview
11.8.3 Aspen API New Chemical Entities (NCE) Introduction
11.8.4 Aspen API Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.8.5 Aspen API Recent Development
11.9 MedPharm
11.9.1 MedPharm Company Details
11.9.2 MedPharm Business Overview
11.9.3 MedPharm New Chemical Entities (NCE) Introduction
11.9.4 MedPharm Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.9.5 MedPharm Recent Development
11.10 Intertek
11.10.1 Intertek Company Details
11.10.2 Intertek Business Overview
11.10.3 Intertek New Chemical Entities (NCE) Introduction
11.10.4 Intertek Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.10.5 Intertek Recent Development
11.11 Neuland Laboratories
11.11.1 Neuland Laboratories Company Details
11.11.2 Neuland Laboratories Business Overview
11.11.3 Neuland Laboratories New Chemical Entities (NCE) Introduction
11.11.4 Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.11.5 Neuland Laboratories Recent Development
11.12 Piramal Pharma Solutions
11.12.1 Piramal Pharma Solutions Company Details
11.12.2 Piramal Pharma Solutions Business Overview
11.12.3 Piramal Pharma Solutions New Chemical Entities (NCE) Introduction
11.12.4 Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.12.5 Piramal Pharma Solutions Recent Development
11.13 Sai Life Sciences
11.13.1 Sai Life Sciences Company Details
11.13.2 Sai Life Sciences Business Overview
11.13.3 Sai Life Sciences New Chemical Entities (NCE) Introduction
11.13.4 Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.13.5 Sai Life Sciences Recent Development
11.14 Chempro Pharma
11.14.1 Chempro Pharma Company Details
11.14.2 Chempro Pharma Business Overview
11.14.3 Chempro Pharma New Chemical Entities (NCE) Introduction
11.14.4 Chempro Pharma Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.14.5 Chempro Pharma Recent Development
11.15 LG Chem
11.15.1 LG Chem Company Details
11.15.2 LG Chem Business Overview
11.15.3 LG Chem New Chemical Entities (NCE) Introduction
11.15.4 LG Chem Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.15.5 LG Chem Recent Development
11.16 Sofpromed
11.16.1 Sofpromed Company Details
11.16.2 Sofpromed Business Overview
11.16.3 Sofpromed New Chemical Entities (NCE) Introduction
11.16.4 Sofpromed Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.16.5 Sofpromed Recent Development
11.17 Aurigene Pharmaceutical Services Ltd.
11.17.1 Aurigene Pharmaceutical Services Ltd. Company Details
11.17.2 Aurigene Pharmaceutical Services Ltd. Business Overview
11.17.3 Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Introduction
11.17.4 Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.17.5 Aurigene Pharmaceutical Services Ltd. Recent Development
11.18 Aragen Life Sciences Ltd
11.18.1 Aragen Life Sciences Ltd Company Details
11.18.2 Aragen Life Sciences Ltd Business Overview
11.18.3 Aragen Life Sciences Ltd New Chemical Entities (NCE) Introduction
11.18.4 Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.18.5 Aragen Life Sciences Ltd Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec New Chemical Entities (NCE) Introduction
11.19.4 WuXi AppTec Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.19.5 WuXi AppTec Recent Development
11.20 PharmaBlock Sciences Nanjing Inc
11.20.1 PharmaBlock Sciences Nanjing Inc Company Details
11.20.2 PharmaBlock Sciences Nanjing Inc Business Overview
11.20.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Introduction
11.20.4 PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (2021–2026)
11.20.5 PharmaBlock Sciences Nanjing Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
KATSURA CHEMICAL CO., LTD
Adragos Pharma
Syngene
Regis Custom API
Bachem
Suven Pharma
Aspen API
MedPharm Ltd.
Intertek
Neuland Laboratories
Piramal Pharma Solutions
Sai Life Sciences
Chempro Pharma
LG Chem
Sofpromed
Aurigene Pharmaceutical Services Ltd.
Aragen Life Sciences Ltd
WuXi AppTec
PharmaBlock Sciences (Nanjing), Inc.
NMS Group (Accelera Srl)
List of Tables
 Table 1. Global New Chemical Entities (NCE) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of NCE Discovery
 Table 3. Key Players of Drug Formulation Development
 Table 4. Key Players of Large-scale Manufacturing
 Table 5. Global New Chemical Entities (NCE) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global New Chemical Entities (NCE) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global New Chemical Entities (NCE) Market Size by Region (US$ Million), 2021–2026
 Table 8. Global New Chemical Entities (NCE) Market Share by Region (2021–2026)
 Table 9. Global New Chemical Entities (NCE) Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global New Chemical Entities (NCE) Market Share by Region (2027–2032)
 Table 11. New Chemical Entities (NCE) Market Trends
 Table 12. New Chemical Entities (NCE) Market Drivers
 Table 13. New Chemical Entities (NCE) Market Challenges
 Table 14. New Chemical Entities (NCE) Market Restraints
 Table 15. Global New Chemical Entities (NCE) Revenue by Players (US$ Million), 2021–2026
 Table 16. Global New Chemical Entities (NCE) Market Share by Players (2021–2026)
 Table 17. Global Top New Chemical Entities (NCE) Players by Tier (Tier 1, Tier 2, and Tier 3), based on New Chemical Entities (NCE) Revenue, 2025
 Table 18. Ranking of Global Top New Chemical Entities (NCE) Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by New Chemical Entities (NCE) Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of New Chemical Entities (NCE), Headquarters and Area Served
 Table 21. Global Key Players of New Chemical Entities (NCE), Products and Applications
 Table 22. Global Key Players of New Chemical Entities (NCE), Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global New Chemical Entities (NCE) Market Size by Type (US$ Million), 2021–2026
 Table 25. Global New Chemical Entities (NCE) Revenue Market Share by Type (2021–2026)
 Table 26. Global New Chemical Entities (NCE) Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global New Chemical Entities (NCE) Revenue Market Share by Type (2027–2032)
 Table 28. Global New Chemical Entities (NCE) Market Size by Application (US$ Million), 2021–2026
 Table 29. Global New Chemical Entities (NCE) Revenue Market Share by Application (2021–2026)
 Table 30. Global New Chemical Entities (NCE) Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global New Chemical Entities (NCE) Revenue Market Share by Application (2027–2032)
 Table 32. North America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
 Table 34. North America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific New Chemical Entities (NCE) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific New Chemical Entities (NCE) Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa New Chemical Entities (NCE) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa New Chemical Entities (NCE) Market Size by Country (US$ Million), 2027–2032
 Table 47. KATSURA CHEMICAL CO., LTD Company Details
 Table 48. KATSURA CHEMICAL CO., LTD Business Overview
 Table 49. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) Product
 Table 50. KATSURA CHEMICAL CO., LTD Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 51. KATSURA CHEMICAL CO., LTD Recent Development
 Table 52. NMS Group (Accelera Srl) Company Details
 Table 53. NMS Group (Accelera Srl) Business Overview
 Table 54. NMS Group (Accelera Srl) New Chemical Entities (NCE) Product
 Table 55. NMS Group (Accelera Srl) Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 56. NMS Group (Accelera Srl) Recent Development
 Table 57. Adragos Pharma Company Details
 Table 58. Adragos Pharma Business Overview
 Table 59. Adragos Pharma New Chemical Entities (NCE) Product
 Table 60. Adragos Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 61. Adragos Pharma Recent Development
 Table 62. Syngene Company Details
 Table 63. Syngene Business Overview
 Table 64. Syngene New Chemical Entities (NCE) Product
 Table 65. Syngene Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 66. Syngene Recent Development
 Table 67. Regis Custom API Company Details
 Table 68. Regis Custom API Business Overview
 Table 69. Regis Custom API New Chemical Entities (NCE) Product
 Table 70. Regis Custom API Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 71. Regis Custom API Recent Development
 Table 72. Bachem Company Details
 Table 73. Bachem Business Overview
 Table 74. Bachem New Chemical Entities (NCE) Product
 Table 75. Bachem Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 76. Bachem Recent Development
 Table 77. Suven Pharma Company Details
 Table 78. Suven Pharma Business Overview
 Table 79. Suven Pharma New Chemical Entities (NCE) Product
 Table 80. Suven Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 81. Suven Pharma Recent Development
 Table 82. Aspen API Company Details
 Table 83. Aspen API Business Overview
 Table 84. Aspen API New Chemical Entities (NCE) Product
 Table 85. Aspen API Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 86. Aspen API Recent Development
 Table 87. MedPharm Company Details
 Table 88. MedPharm Business Overview
 Table 89. MedPharm New Chemical Entities (NCE) Product
 Table 90. MedPharm Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 91. MedPharm Recent Development
 Table 92. Intertek Company Details
 Table 93. Intertek Business Overview
 Table 94. Intertek New Chemical Entities (NCE) Product
 Table 95. Intertek Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 96. Intertek Recent Development
 Table 97. Neuland Laboratories Company Details
 Table 98. Neuland Laboratories Business Overview
 Table 99. Neuland Laboratories New Chemical Entities (NCE) Product
 Table 100. Neuland Laboratories Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 101. Neuland Laboratories Recent Development
 Table 102. Piramal Pharma Solutions Company Details
 Table 103. Piramal Pharma Solutions Business Overview
 Table 104. Piramal Pharma Solutions New Chemical Entities (NCE) Product
 Table 105. Piramal Pharma Solutions Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 106. Piramal Pharma Solutions Recent Development
 Table 107. Sai Life Sciences Company Details
 Table 108. Sai Life Sciences Business Overview
 Table 109. Sai Life Sciences New Chemical Entities (NCE) Product
 Table 110. Sai Life Sciences Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 111. Sai Life Sciences Recent Development
 Table 112. Chempro Pharma Company Details
 Table 113. Chempro Pharma Business Overview
 Table 114. Chempro Pharma New Chemical Entities (NCE) Product
 Table 115. Chempro Pharma Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 116. Chempro Pharma Recent Development
 Table 117. LG Chem Company Details
 Table 118. LG Chem Business Overview
 Table 119. LG Chem New Chemical Entities (NCE) Product
 Table 120. LG Chem Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 121. LG Chem Recent Development
 Table 122. Sofpromed Company Details
 Table 123. Sofpromed Business Overview
 Table 124. Sofpromed New Chemical Entities (NCE) Product
 Table 125. Sofpromed Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 126. Sofpromed Recent Development
 Table 127. Aurigene Pharmaceutical Services Ltd. Company Details
 Table 128. Aurigene Pharmaceutical Services Ltd. Business Overview
 Table 129. Aurigene Pharmaceutical Services Ltd. New Chemical Entities (NCE) Product
 Table 130. Aurigene Pharmaceutical Services Ltd. Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 131. Aurigene Pharmaceutical Services Ltd. Recent Development
 Table 132. Aragen Life Sciences Ltd Company Details
 Table 133. Aragen Life Sciences Ltd Business Overview
 Table 134. Aragen Life Sciences Ltd New Chemical Entities (NCE) Product
 Table 135. Aragen Life Sciences Ltd Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 136. Aragen Life Sciences Ltd Recent Development
 Table 137. WuXi AppTec Company Details
 Table 138. WuXi AppTec Business Overview
 Table 139. WuXi AppTec New Chemical Entities (NCE) Product
 Table 140. WuXi AppTec Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 141. WuXi AppTec Recent Development
 Table 142. PharmaBlock Sciences Nanjing Inc Company Details
 Table 143. PharmaBlock Sciences Nanjing Inc Business Overview
 Table 144. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) Product
 Table 145. PharmaBlock Sciences Nanjing Inc Revenue in New Chemical Entities (NCE) Business (US$ Million), 2021–2026
 Table 146. PharmaBlock Sciences Nanjing Inc Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. New Chemical Entities (NCE) Picture
 Figure 2. Global New Chemical Entities (NCE) Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global New Chemical Entities (NCE) Market Share by Type: 2025 vs 2032
 Figure 4. NCE Discovery Features
 Figure 5. Drug Formulation Development Features
 Figure 6. Large-scale Manufacturing Features
 Figure 7. Global New Chemical Entities (NCE) Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global New Chemical Entities (NCE) Market Share by Application: 2025 vs 2032
 Figure 9. Tumors Case Studies
 Figure 10. Cardiovascular Diseases Case Studies
 Figure 11. Other Case Studies
 Figure 12. New Chemical Entities (NCE) Report Years Considered
 Figure 13. Global New Chemical Entities (NCE) Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global New Chemical Entities (NCE) Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global New Chemical Entities (NCE) Market Share by Region: 2025 vs 2032
 Figure 16. Global New Chemical Entities (NCE) Market Share by Players in 2025
 Figure 17. Global New Chemical Entities (NCE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by New Chemical Entities (NCE) Revenue in 2025
 Figure 19. North America New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America New Chemical Entities (NCE) Market Share by Country (2021–2032)
 Figure 21. United States New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe New Chemical Entities (NCE) Market Share by Country (2021–2032)
 Figure 25. Germany New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific New Chemical Entities (NCE) Market Share by Region (2021–2032)
 Figure 33. China New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America New Chemical Entities (NCE) Market Share by Country (2021–2032)
 Figure 41. Mexico New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa New Chemical Entities (NCE) Market Share by Country (2021–2032)
 Figure 45. Israel New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE New Chemical Entities (NCE) Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. KATSURA CHEMICAL CO., LTD Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 49. NMS Group (Accelera Srl) Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 50. Adragos Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 51. Syngene Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 52. Regis Custom API Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 53. Bachem Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 54. Suven Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 55. Aspen API Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 56. MedPharm Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 57. Intertek Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 58. Neuland Laboratories Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 59. Piramal Pharma Solutions Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 60. Sai Life Sciences Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 61. Chempro Pharma Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 62. LG Chem Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 63. Sofpromed Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 64. Aurigene Pharmaceutical Services Ltd. Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 65. Aragen Life Sciences Ltd Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 66. WuXi AppTec Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 67. PharmaBlock Sciences Nanjing Inc Revenue Growth Rate in New Chemical Entities (NCE) Business (2021–2026)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Chemical Drug CDMO Market Research Report 2024
Global Metal Ion Chelator Market Research Report 2025
Global Drug Discovery CRO Market Research Report 2025
Global Paper Release Agent Market Research Report 2025
Global Polymer Antibacterial Agent Market Research Report 2025
Global Textile Antistatic Agent Market Research Report 2025
Global Drug Discovery Software Market Insights Forecast to 2030
Global Antibacterial Additives Market Research Report 2025
Global Alkaline Curing Agent for Epoxy Resin Market Research Report 2025
Novel Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global High Purity Alkanolamide Market Research Report 2025
Drug Discovery and Preclinical CRO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global New Chemical Entities NCE CDMO Market Research Report 2025
Global Molecular Imaging Agents Market Research Report 2024
Global Chemical Drug CXO Services Market Research Report 2024
Global New Electronic Chemical Materials Market Research Report 2024
Investigational New Drug Contract Development and Manufacturing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computational Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epoxy Resin Acid Curing Agent Market Research Report 2025
Global Large Molecule Drug Substance CDMO Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions